Google DeepMind CEO: This year will start clinical trials for AI anti-cancer drugs, with robotic breakthroughs expected in the next 18 months
I'm PortAI, I can summarize articles.
DeepMind CEO revealed that its AI drug development company has 17 projects in progress, with the first clinical trial for an anti-cancer drug expected to start in early 2026; Gemini 3 has crossed a capability watershed, predicting that robotic technology will experience a breakthrough moment in the next 18 months; smart glasses will become the killer hardware for AI; AI will completely reshape the healthcare and energy industries, and humanity is standing at the entrance of a "new renaissance" and a "golden age of discovery."
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments